Aptinyx

NASDAQ APTX
$0.10 0.0029 3.02%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 15 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

6.50M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

-24.80M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

1.36
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

67.72M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-

Upcoming events Aptinyx

All events
No upcoming events scheduled

Stock chart Aptinyx

Stock analysis Aptinyx

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.23 27.69
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
0.17 3.65
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
0.39 9.48
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.49 -0.16
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-156.68 7.67

Price change Aptinyx per year

2.15$ 4.73$
Min Max

Summary analysis Aptinyx

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Aptinyx

Revenue and net income Aptinyx

All parameters

About company Aptinyx

Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic peripheral neuropathy, as well as in Phase II clinical trial for treating fibromyalgia. It is also developing NYX-783, an N-methyl-D-aspartate receptors (NMDAr) modulator that is in Phase I clinical trial to treat post-traumatic stress disorder; and NYX-458, an NMDAr modulator, which is in Phase I clinical study for the treatment of Parkinson's disease cognitive impairment. The company has a research collaboration agreement with Allergan plc; and with Rosalind Franklin University of Medicine and Science. Aptinyx Inc. was incorporated in 2015 and is headquartered in Evanston, Illinois.
Address:
909 Davis Street, Evanston, IL, United States, 60201
Company name: Aptinyx
Issuer ticker: APTX
ISIN: US03836N1037
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2018-06-21
Sector: Healthcare
Industry: Biotechnology
Site: https://www.aptinyx.com

On which stock exchange are Aptinyx (APTX) stocks traded?

Aptinyx (APTX) stocks are traded on NASDAQ.

What is the ticker of Aptinyx stocks (APTX)?

The stock ticker of Aptinyx’s stocks or in other words, the code is APTX. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Aptinyx (APTX) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Aptinyx (APTX) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Aptinyx (APTX) stocks traded?

Aptinyx (APTX) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Aptinyx (APTX) stocks today?

The current price of Aptinyx stocks on 08.05.2024 is 0.096 dollars. per share.

What is the dynamics of Aptinyx (APTX) stocks from the beginning of the year?

Aptinyx (APTX) quotes have increased by 0% from the beginning of the year up to 0.096 dollars. per 1 stocks.

How much did Aptinyx (APTX) stocks increase in мае 2024?

This month Aptinyx (APTX) quotes have increased by 0% to 0.096 dollars. per share.

How much are Aptinyx (APTX) stocks worth?

Today, on October, 08.05.2024 Aptinyx’s (APTX) stocks cost 0.096 dollars..

What is the market capitalization of Aptinyx (APTX)?

Capitalization is the market value of Aptinyx (APTX) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 08.05.2024, the market capitalization of Aptinyx (APTX) is estimated at about 6500736 dollars.